AR032614A1 - Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina - Google Patents

Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina

Info

Publication number
AR032614A1
AR032614A1 ARP010100957A ARP010100957A AR032614A1 AR 032614 A1 AR032614 A1 AR 032614A1 AR P010100957 A ARP010100957 A AR P010100957A AR P010100957 A ARP010100957 A AR P010100957A AR 032614 A1 AR032614 A1 AR 032614A1
Authority
AR
Argentina
Prior art keywords
oral administration
ciprofloxacine
administration system
daily intake
agent
Prior art date
Application number
ARP010100957A
Other languages
English (en)
Spanish (es)
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of AR032614A1 publication Critical patent/AR032614A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP010100957A 2000-03-03 2001-02-28 Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina AR032614A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03

Publications (1)

Publication Number Publication Date
AR032614A1 true AR032614A1 (es) 2003-11-19

Family

ID=24061635

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100957A AR032614A1 (es) 2000-03-03 2001-02-28 Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina

Country Status (31)

Country Link
EP (1) EP1263409A1 (et)
JP (1) JP2003525229A (et)
KR (1) KR20030009374A (et)
CN (1) CN1420763A (et)
AP (2) AP1485A (et)
AR (1) AR032614A1 (et)
AU (1) AU3589701A (et)
BG (1) BG107055A (et)
BR (1) BR0108958A (et)
CA (1) CA2400950A1 (et)
CZ (1) CZ20022883A3 (et)
DO (1) DOP2001000130A (et)
EA (1) EA200200914A1 (et)
EC (1) ECSP013952A (et)
EE (1) EE200200497A (et)
GT (1) GT200100033A (et)
HN (1) HN2001000038A (et)
HR (1) HRP20020715A2 (et)
HU (1) HUP0204417A3 (et)
IL (1) IL151553A0 (et)
IS (1) IS6532A (et)
MX (1) MXPA02008568A (et)
NO (1) NO20024108L (et)
NZ (1) NZ520927A (et)
OA (1) OA12381A (et)
PE (1) PE20011113A1 (et)
PL (1) PL365071A1 (et)
SK (1) SK12542002A3 (et)
WO (1) WO2001064183A1 (et)
YU (1) YU66202A (et)
ZA (1) ZA200206764B (et)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109806237A (zh) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 一种乳酸环丙沙星泡腾片及其制备方法

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
ATE396710T1 (de) * 2005-07-19 2008-06-15 Ethypharm Sa Gastroretentive zusammensetzungen und verfahren zur herstellung
EP1880722B1 (en) * 2006-07-19 2010-03-17 Tabuk Pharmaceutical Manufacturing Co. Pharmaceutical compositions of ciprofloxacin
EP3247384B1 (en) 2015-01-14 2023-10-04 The Regents of the University of Colorado, a body corporate In vitro method of diagnosis of type 1 diabetes with insulin mimotopes
CA3015400A1 (en) * 2016-02-23 2017-08-31 Matripharm International Inc. Dual-rate release formulation with high drug loading
WO2017165508A1 (en) 2016-03-24 2017-09-28 Im Therapeutics Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
DE19839057A1 (de) * 1998-08-28 2000-03-02 Koch Berthold Spülluft-Regler für eine Trockenvorrichtung für Druckluft
CZ2001901A3 (cs) * 1998-09-14 2001-08-15 Ranbaxy Laboratories Limited Farmaceutická kompozice představující systém řízeného dodávání léku pro orální podání, poskytující časovou a místní kontrolu

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109806237A (zh) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 一种乳酸环丙沙星泡腾片及其制备方法

Also Published As

Publication number Publication date
MXPA02008568A (es) 2003-02-24
JP2003525229A (ja) 2003-08-26
YU66202A (sh) 2005-09-19
SK12542002A3 (sk) 2003-05-02
PL365071A1 (en) 2004-12-27
ZA200206764B (en) 2003-03-04
GT200100033A (es) 2001-10-25
HUP0204417A2 (en) 2003-05-28
EA200200914A1 (ru) 2003-02-27
HRP20020715A2 (en) 2004-12-31
DOP2001000130A (es) 2004-03-31
IS6532A (is) 2002-08-28
CN1420763A (zh) 2003-05-28
CZ20022883A3 (cs) 2003-04-16
AU3589701A (en) 2001-09-12
NO20024108D0 (no) 2002-08-28
CA2400950A1 (en) 2001-09-07
BR0108958A (pt) 2003-09-30
AP1485A (en) 2005-10-31
BG107055A (bg) 2003-06-30
NO20024108L (no) 2002-10-25
PE20011113A1 (es) 2001-10-14
HN2001000038A (es) 2005-03-23
IL151553A0 (en) 2003-04-10
AP2001002084A0 (en) 2001-03-31
OA12381A (en) 2004-09-06
EE200200497A (et) 2004-02-16
WO2001064183A1 (en) 2001-09-07
NZ520927A (en) 2003-06-30
HUP0204417A3 (en) 2005-03-29
ECSP013952A (es) 2002-04-23
AP2002002627A0 (en) 2002-09-30
EP1263409A1 (en) 2002-12-11
KR20030009374A (ko) 2003-01-29

Similar Documents

Publication Publication Date Title
IT1276689B1 (it) Forma farmaceutica solida ad uso orale
ATE386508T1 (de) Feste orale dosierungsform enthaltend einen resorptionsverstärker
DE60121570D1 (de) Oral anzuwendende schnell zerfallende feste darreichungsformen
BR0215184A (pt) composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada
NO993520L (no) Doseringsformer og fremgangsmÕte for Õ bedre erektil dysfunksjon
DE59802670D1 (de) Osmotisches arzneimittelfreisetzungssystem
PE20030602A1 (es) Composicion farmaceutica que comprende un macrolido
HRP20030951B1 (hr) Formulacije jednodnevnih doza oksikodona
RS50303B (sr) Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem
CO5280073A1 (es) Composiciones
AR032614A1 (es) Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
BR0209283A (pt) Método para a fabricação de uma composição farmacêutica de baixa dosagem tendo distribuição e potência de droga uniforme
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
AR011919A1 (es) FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA
NO20034863L (no) Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
PT1425005E (pt) Composicao farmaceutica que compreende lumiracoxib
MY129314A (en) Pharmaceutical composition comprising sumatriptan
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
BR0209155A (pt) Tablete farmacêutico tendo um teor de api elevado
SE0001916D0 (sv) Novel formulation
MA26788A1 (fr) COMPOSITIONS PHARMACEUTIQUES DESTINÉES à L'ADMINISTRATION PAR VOIE ORALE DE PHLOROGLUCINOL ET LEUR PRÉPARATION
AR039162A1 (es) Formulaciones de venlafaxina de liberacion extendida
UY26605A1 (es) Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal